Floatz logo

CLOMIPHENE CITRATE

Anovulation

Xiyuan Hospital of China Academy of Chinese Medical SciencesSmall moleculePhase 4 / ApprovedDormant
BBB
79/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
68/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Anovulation cohort.

View all 15

Same molecule, other indications

CLOMIPHENE CITRATE is also rated in:

infertility disorderActive
A
Indicative · Phase 4
81 / 100
View asset →
polycystic ovary syndromeActive
BBB
Indicative · Phase 4
74 / 100
View asset →
pregnancy disorderDormant
BB
Indicative · Phase 3
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →